Medication info
Depoteriem Extended-Release Tablet 20/1000 mg (Teneligliptin Hydrate, Metformin Hydrochloride)

Depoteriem Extended-Release Tablet 20/1000 mg (Teneligliptin Hydrate, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Iyeon Pharmaceutical Co., Ltd.
Appearance
Pink egg-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201303 · Approved 2022.04.04 · Insurance code 658604700

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Iyeon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It effectively controls blood sugar through the combined administration of teneligliptin and metformin, helping in the management of diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and helps regulate blood sugar levels. However, there are several precautions to consider while taking this medication. First, this medication can rarely cause a serious condition called lactic acidosis, which is a dangerous state caused by excessive accumulation of lactic acid in the body. Patients with impaired kidney function or heart problems, as well as those with acute infections or trauma, should avoid taking this medication due to potential risks. Additionally, this medication should be temporarily discontinued before radiological examinations, and should only be resumed after confirming normal renal function post-examination. Women who are pregnant or may become pregnant are advised not to take this medication for safety reasons. This medication may cause hypoglycemia when used with other glucose-lowering agents, so patients must be aware of hypoglycemia symptoms and how to manage them. Regular checks of liver and kidney function during treatment are crucial to ensure there are no abnormalities. Furthermore, alcohol consumption should be avoided as it may increase the risk of lactic acidosis. Some patients may experience side effects such as indigestion, diarrhea, and dizziness, while rare but serious adverse reactions like liver dysfunction, pneumonia, or skin rashes may occur. If severe abdominal pain, vomiting, or skin blisters or rashes occur, immediate consultation with a physician is necessary. Elderly patients may have reduced kidney function, so dose adjustment and monitoring of kidney function are especially important. During treatment with this medication, regular testing of blood sugar and vitamin B12 levels is essential to prevent deficiencies. In case of overdose, seek medical attention immediately for appropriate treatment, and blood dialysis may be performed to remove the medication if necessary. Finally, this medication has not been established as safe or effective in children and should not be used. It is crucial to use this medication safely under regular medical supervision and according to the physician's instructions.

Side effects

Severe lactic acidosis, hypoglycemia, intestinal obstruction, liver dysfunction, interstitial pneumonia, pseudo-pemphigus, acute pancreatitis, dizziness, constipation, abdominal bloating, abdominal discomfort, nausea, abdominal pain, distension, stomatitis, gastric polyps, colon polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, loss of appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, increased CK (CPK), elevated serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremor, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, pruritus, diabetic retinopathy, decreased vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hypertrophy, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, reduced neutrophil count, abnormal blood sugar, increased blood sugar, elevated blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc protrusion of the spine, intervertebral disc disorder of the spine, spinal ligament ossification, foraminal stenosis of the spine, rotator cuff syndrome, bladder mass, ureteral calculus, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, dysesthesia, headache, hepatic coma, sensory disturbance, sensory impairment, tension headache, peripheral neuropathy, facial paralysis, sciatica, orthostatic dizziness, muscle weakness, low back pain, limb pain, lumbar spinal canal stenosis, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasm, foot deformity, hypertrophic osteoarthropathy, bursitis, spinal osteoarthritis, intervertebral disc protrusion of the spine, intervertebral disc disorder of the spine, spinal ligament ossification, foraminal stenosis of the spine, postmenopausal osteoporosis, rotator cuff syndrome, gastroenteritis, vomiting, chronic gastritis, upper abdominal pain, abdominal pain, gastrointestinal motility disorder, reduced gastrointestinal motility, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, increased blood sugar, abnormal phlegm, increased blood creatinine, increased blood urea, anemia, food allergy, pressure ulcer, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, dizziness, iron deficiency anemia, urticaria, hearing loss, endolymphatic hydrops, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure. The appropriate storage temperature is room temperature between 1 degree and 30 degrees Celsius. Avoid storing in excessively hot or cold places.

Appearance and packaging

Appearance

Pink egg-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.